171 related articles for article (PubMed ID: 9271778)
1. Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression.
König F; Wolfersdorf M; Löble M; Wössner S; Hauger B
Pharmacopsychiatry; 1997 Jul; 30(4):125-7. PubMed ID: 9271778
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
König F; Wolfersdorf M
Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
Becker T; Struck M; Laux G
Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
[TBL] [Abstract][Full Text] [Related]
4. [Moclobemide in the long-term treatment of depressed patients].
Carl G; Laux G
Psychiatr Prax; 1989 Aug; 16 Suppl 1():48-50. PubMed ID: 2511580
[TBL] [Abstract][Full Text] [Related]
5. [Treatment with selective and reversible monoamine oxidase inhibitors in depressed patients: is there a biological effect proportional to the dose?].
Radat F; Berlin I; Varoquaux O; Ferreri M; Puech A
Ann Med Psychol (Paris); 1996 Jun; 154(3):204-6. PubMed ID: 8766502
[No Abstract] [Full Text] [Related]
6. [Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
Classen W
Psychiatr Prax; 1989 Aug; 16 Suppl 1():41-3. PubMed ID: 2587675
[TBL] [Abstract][Full Text] [Related]
7. Reversible monoamine oxidase-A inhibitors in resistant major depression.
Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
[TBL] [Abstract][Full Text] [Related]
8. Acute therapy of depression.
Bech P
J Clin Psychiatry; 1993 Aug; 54 Suppl():18-27; discussion 28. PubMed ID: 8253702
[TBL] [Abstract][Full Text] [Related]
9. RIMA: a safe concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of moclobemide in therapy-resistant depression].
Andriushchenko AV; Kolesnikov DB
Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):34-7. PubMed ID: 9819886
[TBL] [Abstract][Full Text] [Related]
11. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
Kennedy SH
J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
[TBL] [Abstract][Full Text] [Related]
12. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
Kok LP; Tsoi WF
Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of pharmaco-EEG in depression treated with moclobemide].
Wiśniewski G; Jakitowicz J; Nowicki Z; Pankiewicz P
Psychiatr Pol; 2002; 36(6 Suppl):93-8. PubMed ID: 12647427
[TBL] [Abstract][Full Text] [Related]
14. Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.
Nair NP; Ahmed SK; Kin NM
J Psychiatry Neurosci; 1993 Nov; 18(5):214-25. PubMed ID: 7905288
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of single-point sampling strategies for the estimation of moclobemide exposure in depressive patients.
Ignjatovic AR; Miljkovic B; Todorovic D; Timotijevic I; Pokrajac M
J Clin Pharmacol; 2011 May; 51(5):661-71. PubMed ID: 20495135
[TBL] [Abstract][Full Text] [Related]
16. [Preventive treatment of migraine and chronic tension headache with moclobemide].
Meienberg O; Amsler F
Praxis (Bern 1994); 1997 Jul; 86(27-28):1107-12. PubMed ID: 9324719
[TBL] [Abstract][Full Text] [Related]
17. Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder.
Laux G; Beckmann H; Classen W; Becker T
J Neural Transm Suppl; 1989; 28():45-52. PubMed ID: 2677241
[TBL] [Abstract][Full Text] [Related]
18. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
[TBL] [Abstract][Full Text] [Related]
19. Moclobemide for depression.
Drug Ther Bull; 1994 Jan; 32(1):6-8. PubMed ID: 7635005
[TBL] [Abstract][Full Text] [Related]
20. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
Botte L; Evrard JL; Gilles C; Stenier P; Wolfrum C
Acta Psychiatr Belg; 1992; 92(6):355-69. PubMed ID: 1345409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]